Product Information
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET is a generic product labeled by Winder Laboratories LLC, priced at $0.1386 per EA under NDC 75826010700. Its NADAC has been published 203 times since Oct 5, 2022.
FDA first approved this application on Jan 27, 2021. Its Orange Book therapeutic-equivalence code is AA.
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET
Diphenoxylate Hydrochloride and Atropine SulfateStrength
.025; 2.5 mg/1; mg/1
Manufacturer
Winder Laboratories LLCNDC
75826010700
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211362FDA Approved
1/27/2021
TE Code
AA
On Market Since
4/30/2022
Pharmacological Classes
Price Statistics
The NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has been published 203 times since Oct 5, 2022, and over the history we have for it it has declined 35.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1386 per EA |
|---|---|
| All-time high | $0.2446 (Apr 10, 2024) |
| All-time low | $0.1298 (Nov 20, 2024) |
| 52-week high | $0.1837 |
| 52-week low | $0.1371 |
| Median price | $0.1772 |
| Average price | $0.1770 |
| Largest weekly change | +55.5% (Aug 21, 2024) |
| Weeks tracked | 203 |
| Tracking since | Oct 5, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET, manufactured by Winder Laboratories LLC, is $0.1386 per EA (NDC 75826010700), effective Aug 19, 2026.
How has the price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has declined 35.3%. It has been tracked across 203 weekly CMS publications since Oct 5, 2022.
What are the highest and lowest recorded NADAC prices for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
Since Oct 5, 2022, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has ranged from a low of $0.1298 (Nov 20, 2024) to a high of $0.2446 (Apr 10, 2024), with a median of $0.1772 per EA.
Are there cheaper alternatives to DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET (NDC 75826010700) is labeled by Winder Laboratories LLC, and CMS classifies it as a generic product.